Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Cancer clocks in tumourigenesis : the p53 pathway and beyond

Tools
- Tools
+ Tools

Stephenson, Ewan Michael, Usselmann, Laura Emma Jane, Tergaonkar, Vinay, Virshup, David and Dallmann, Robert (2021) Cancer clocks in tumourigenesis : the p53 pathway and beyond. Endocrine-Related Cancer . doi:10.1530/ERC-20-0475 (In Press)

[img]
Preview
PDF
WRAP-cancer-clocks-tumourigenesis-p53-pathway-beyond-Dallmann-2021.pdf - Accepted Version - Requires a PDF viewer.

Download (1480Kb) | Preview
Official URL: http://dx.doi.org/10.1530/ERC-20-0475

Request Changes to record.

Abstract

Circadian rhythms regulate a vast array of physiological and cellular processes, as well as the hormonal milieu, to keep our cells synchronised to the light-dark cycle. Epidemiologic studies have implicated circadian disruption in the development of breast and other cancers, and numerous clock genes are dysregulated in human tumours. Here we review the evidence that circadian rhythms, when altered at the molecular level, influence cancer growth. We also note some common pitfalls in circadian-cancer research and how they might be avoided to maximise comparable results and minimise misleading data. Studies of circadian gene mutant mice, and human cancer models in vitro and in vivo, demonstrate that clock genes can impact tumourigenesis. Clock genes influence important cancer related pathways, ranging from p53-mediated apoptosis to cell cycle progression. Confusingly, clock dysfunction can be both pro- or anti- tumourigenic in a model and cell type specific manner. Due to this duality, there is no canonical mechanism for clock interaction with tumourigenic pathways. To understand the role of the circadian clock in patients’ tumours requires analysis of the molecular clock status compared to healthy tissue. Novel mathematical approaches are under development, but this remains largely aspirational, and is hampered by a lack of temporal information in publicly available datasets. Current evidence broadly supports the notion that the circadian clock is important for cancer biology. More work is necessary to develop an overarching model of this connection. Future studies would do well to analyse the clock network in addition to alterations in single clock genes.

Item Type: Journal Article
Subjects: Q Science > QP Physiology
R Medicine > RC Internal medicine
Divisions: Faculty of Medicine > Warwick Medical School > Biomedical Sciences
Faculty of Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine
Faculty of Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH): Cancer, Tumors, p53 antioncogene, Circadian rhythms
Journal or Publication Title: Endocrine-Related Cancer
Publisher: BioScientifica
ISSN: 1351-0088
Official Date: 1 February 2021
Dates:
DateEvent
1 February 2021Available
19 February 2021Accepted
Date of first compliant deposit: 2 March 2021
DOI: 10.1530/ERC-20-0475
Status: Peer Reviewed
Publication Status: In Press
Publisher Statement: Disclaimer: this is not the definitive Version of Record of this article. This manuscript has been accepted for publication in Endocrine-Related Cancer, but the version presented here has not yet been copy-edited, formatted or proofed. Consequently, Bioscientifica accepts no responsibility for any errors or omissions it may contain.
Access rights to Published version: Restricted or Subscription Access
RIOXX Funder/Project Grant:
Project/Grant IDRIOXX Funder NameFunder ID
Warwick A*STAR Research Attachment Programme (ARAP)University of Warwickhttp://dx.doi.org/10.13039/501100000741
UNSPECIFIEDAgency for Science, Technology and Researchhttp://dx.doi.org/10.13039/501100001348
UNSPECIFIEDUniversity of Warwickhttp://dx.doi.org/10.13039/501100000741
MR/N014294/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
UNSPECIFIEDInstitute of Molecular and Cell Biologyhttp://dx.doi.org/10.13039/501100007674
NRF-CRP17-2017-02National Research Foundation Singaporehttp://dx.doi.org/10.13039/501100001381
NMRC/CIRG/1465/2017National Medical Research Councilhttp://dx.doi.org/10.13039/501100001349
Warwick Innovation FundUniversity of Warwickhttp://dx.doi.org/10.13039/501100000741
C53720/A29468Cancer Research UKhttp://dx.doi.org/10.13039/501100000289

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us